Document Type : Review / Mini-Review
Authors
Centre for Liver research and Diagnostics, Deccan College of Medical Sciences, Kanchanbagh
Abstract
Increasing incidence of central nervous system (CNS) disorders has become a major challenge for both basic and clinical scientific society to develop novel therapeutic models for treatment. The knowledge of stem cells has added a new dimension in the research towards finding more appropriate targets responsible for the disease fate determination. As stem cell research is progressing day by day in routine research laboratories there is great hope to find suitable therapeutic targets for complete cure of the CNS disorders. Discovery of ABC transporters in animal tissues has emerged as new spot for several disease prognosis and therapeutic target. ABC transporters are membrane proteins expressed in various organs like liver, kidney, blood-brain barrier, blood-testis barrier etc. It is involved in various important cellular processes such as absorption, distribution and excretion of drugs, xenobiotics and endogenous compounds showing their role in tissue defense and organ regeneration. The current review explains about the role of ABC transporters in CNS pathogenesis and defense adding stem cells therapeutic strategies.
Keywords
1. Abdullah LN and Chow EK 2013 Mechanisms of chemoresistance in cancer stem cells. Clinic. & Translat. Med. 2 (3).
2. Alberto L, Fabiana L, Sandra C, Vicente C and Analia T 2014 Stem-cell marker CD34, multidrug resistance proteins P-gp and BCRP in SEGA. Recept. & Clinic. Invest. 1.
3. Alison MR, Poulsom R, Jeffery R, Dhillon AP and Quaglia A, et al 2000 Hepatocytes from non-hepatic adult stem cells. Nat. 406 257.
4. Asakura A and Rudnicki MA 2002 Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp. Hematol. 30 1339–1345.
5. Begley DJ 2004 ABC transporters and the blood-brain barrier. Curr. Pharm. Des. 10 1295–1312.
6. Chaudhary PM and Roninson IB 1991 Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell. 66 85–94.
7. Chung-Pu Wu, Anna Maria Calcagno, and Suresh VA 2008 Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: Evaluation of current strategies. Curr. Mol. Pharmacol. 2008 1(2) 93–105.
8. Dean M 2005 The genetics of ATP-binding cassette transporters. Meth. Enzymol. 400 409–429
9. Elzbieta IS, Cassandra JR, and Christian MP 2011 Regulation of ABC Transporter Function Via Phosphorylation by Protein Kinases. Curr. Pharm. Biotechnol. 1 12(4) 621–635.
10. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, and Mavilio F 1998 Muscle regeneration by bone marrow-derived myogenic progenitors. Sci. 279 1528–1530.
11. Gangavarapu KJ, Azabdaftari G, Morrison CD, Miller A and Foster BA, et al 2013 Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity. Stem Cell Res. Ther. 4 (5) 132.
12. Glaeser H and Fromm MF 2008 Animal models and intestinal drug transport. Exp. Opin. Drug Metab. Toxicol. 4 347–361.
13. Golebiewska A, Brons NHC, Bjerkvig R and Niclou SP 2011 Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research. Cell Stem Cell. 8 136-147.
14. Hartz AMS and Bauer B 2010 Regulation of ABC transporters at the blood-brain barrier: New targets for CNS therapy. Mol. Interv. 10 5.
15. Honjo Y, Hrycyna CA, Yan QW, Medina-Pe´rez WY and Robey RW, et al 2001 Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Canc. Res. 61 6635–6639.
16. Ingram WJ, Crowther LM, Little EB, Freeman R and Hallahan AR et al 2013 ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma. Exp. Hematol. Oncol. 2 (26).
17. Ishimoto T, Nakamichi N, Hosotani H, Masuo Y and Sugiura T, et al 2014 Organic Cation Transporter-Mediated Ergothioneine Uptake in Mouse Neural Progenitor Cells Suppresses Proliferation and Promotes Differentiation into Neurons. PLoS ONE. 9 (2).
18. Jackson KA, Majka SM, Wang H, Pocius J and Hartley CJ, et al 2001 Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107 1395–1402.
19. Jackson KA, Mi T, and Goodell MA 1999 Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 96 14482–14486.
20. Krause DS, Theise ND, Collector MI, Henegariu O and Hwang S, et al 2001 Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 105 369–377.
21. Kusuhara H and Sugiyama Y 2001 Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (part 1). Drug. Discov. Today. 6 150–156.
22. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M and Dohse M, et al 2000 Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6 1229–1234.
23. Larderet G, Fortunel NO, Vaigot P, Cegalerba M and Malte`re P, et al 2006 Human side population keratinocytes exhibit long-term proliferative potential and a specific gene expression profile and can form a pluristratified epidermis. Stem Cells. 24 965–974.
24. Leslie EM, Deeley RG, and Cole SP 2005 Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204 216–237.
25. Litman T, Brangi M, Hudson E, Fetsch P and Abati A, et al 2000 The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell. Sci. 113 2011–2021.
26. Mangum R, Nakano I 2011 Glioma Stem Cells and their Therapy Resistance. J Carcinogene Mutagene S1:002.
27. Mezey E, Chandross KJ, Harta G, Maki RA, and McKercher SR 2000 Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Sci. 290 1779–1782.
28. Ni Z and Mao Q 2011 ATP-binding cassette efflux transporters in human placenta. Curr. Pharm. Biotechnol. 12(4) 674-685.
29. Padmanabhan R, Chen KG, Gillet JP, Handley M and Mallon BS, et al 2012 Regulation and Expression of the ATP-Binding Cassette Transporter ABCG2 in Human Embryonic Stem Cells. Stem Cells 30 (10) 2175–2187.
30. Perrie`re N, Yousif S, Cazaubon S, Chaverot N and Bourasset F, et al 2007 A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain. Res. 1150 1–13.
31. Russel FG, Masereeuw R, and Van Aubel RA 2002 Molecular aspects of renal anionic drug transport. Ann. Rev. Physiol. 64 563–594.
32. Schinkel A. H. 1997 The physiological function of drug-transporting P-glycoproteins. Semin. Canc. Biol. 8 161–170
33. Schumacher T, Krohn M, Hofrichter J, Lange C and Stenzel J, et al. 2012 ABC Transporters B1, C1 and G2 Differentially Regulate Neuroregeneration in Mice. PLoS ONE. 7(4) e35613.
34. Solomon OU and Jian T 2012 Bench to Bedside of Neural Stem Cell in Traumatic Brain Injury. Stem Cells Internat. 8.
35. Szaka´cs G, Va´radi A, Ozvegy-Laczka C, and Sarkadi B 2008 The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug. Discov. Today. 13 379–393.
36. To Kenneth KW and Fu LW 2011 Multidrug Resistance Transporters – Roles in maintaining Cancer Stem-Like Cells, Stem Cells in Clinic and Research, Dr. Ali Gholamrezanezhad (Ed.), InTech.
37. Xia CQ, Milton MN, and Gan LS 2007 Evaluation of drug-transporter interactions using in vitro and in vivo models. Curr. Drug Metab. 8 341–363.
38. Yano S, Ito Y, Fujimoto M, Hamazaki TS, Tamaki K, and Okochi H 2005 Characterization and localization of side population cells in mouse skin. Stem Cells. 23 834–841.
39. Zheng X, Naiditch J, Czurylo M, Jie C and Lautz T, et al 2013 Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics. Cell Death and Disease. 4 e740.
40. Zhou S, Schuetz JD, Bunting KD, Colapietro AM and Sampath J, et al 2001 The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7 1028–1034.
)
Send comment about this article